MD Anderson Cancer Center unveils cell therapy research institute that will work with biotech, pharma

With more than $80 million in hand, the University of Texas MD Anderson Cancer Center has launched its own cell therapy institute.

Dubbed the Institute for Cell Therapy Discovery & Innovation, the organization will lead discovery work and clinical research in immunology and cell engineering to develop new treatments for cancer, autoimmune diseases, infections and other conditions, according to a Nov. 8 release.